Skip to content
RP
Company

Updated:

REATA PHARMACEUTICALS INC

REATA PHARMACEUTICALS INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001358762, and its reported...

Overview

REATA PHARMACEUTICALS INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001358762, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2023-02-24, it reported annual revenue of USD 2,216,000; net income of USD -311,901,000; total assets of USD 514,491,000 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

Company overview

Legal name
REATA PHARMACEUTICALS INC
Classification
Company
Industry (SIC)
2834 — Pharmaceutical Preparations
Headquarters
Plano, TX, United States
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
0001358762

Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

Fiscal yearPeriod endRevenueNet incomeTotal assetsCash and equivalentsOperating cash flow
FY2022USD$2.2M-$311.9M$514.5M$42.3M-$204.3M
FY2021USD$11.5M-$297.4M$735.0M$590.3M-$235.7M
FY2020USD$9.0M-$247.8M$857.6M$818.1M-$322.3M
FY2019USD$26.5M-$290.2M$682.4M$664.3M-$251.2M

Recent SEC filings

FormFiledPeriodFiling
8-K8-K
8-K8-K
8-K8-K
10-Q10-Q
SC 13D—SC 13D
8-K8-K
8-K8-K
8-K8-K
SC 13G—REATA PHARMACEUTICALS, INC.
8-K8-K
8-K8-K
10-Q10-Q

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research REATA PHARMACEUTICALS INC in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More Company profiles

REATA PHARMACEUTICALS INC | Plano Company | Altss